Supramolecular RNAi with multifunctional siRNA nanostructures.

Area of Science:

• Biotechnology
• Nanomedicine
• RNA Therapeutics

Background:

• Supramolecular RNA nanostructures are emerging as advanced genetic tools in biomedicine.
• Genetically encoded short interfering RNA (siRNA) nanostructures offer precise oncogene silencing for cancer gene therapy.

Purpose of the Study:

• To design and synthesize V- and Y-shaped branched RNA templates for assembling 2D and 3D siRNA nanostructures.
• To target Glucose Regulated Proteins (GRP75, 78, 94, 170) mRNA transcripts in cancer cells.
• To investigate the anti-cancer activity of these novel nanostructures.

Main Methods:

• Synthesis of V- and Y-shaped branched RNA templates.
• Scaffolding of self-assembled 2D and 3D siRNA nanostructures (nano-squares, -cubes, -tubes).
• Structure and stability analyses, bioconjugation with fluorescent reporters (fluorescein, coumarin) for FRET-based monitoring.
• In vitro studies using human adenocarcinoma (A549) cell line.

Main Results:

• Formation of well-defined siRNA nano-squares, -cubes, and -tubes with specific supramolecular and biophysical properties.
• Successful incorporation of fluorescent reporters for real-time monitoring of nanostructure assembly.
• Demonstrated cell uptake and intracellular localization of siRNA nanostructures in A549 cells.
• Significant anti-proliferative and toxicity effects observed, indicating anti-cancer activity via GRP silencing.

Conclusions:

• The study highlights the innovation of multifunctional siRNA nanostructures for cancer gene-silencing therapies.
• These nanostructures show potential for precise targeting and effective elimination of cancer cells.
• Further research is warranted to explore their therapeutic applications in oncology.